These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8616529)
21. Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus. Guardado-Mendoza R; Chávez AO; Jiménez-Ceja LM; Hansis-Diarte A; DeFronzo RA; Folli F; Tripathy D Acta Diabetol; 2017 Jan; 54(1):53-61. PubMed ID: 27624579 [TBL] [Abstract][Full Text] [Related]
22. Integrated mathematical model to assess beta-cell activity during the oral glucose test. Thomaseth K; Kautzky-Willer A; Ludvik B; Prager R; Pacini G Am J Physiol; 1996 Mar; 270(3 Pt 1):E522-31. PubMed ID: 8638701 [TBL] [Abstract][Full Text] [Related]
23. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function? Stadler M; Anderwald C; Karer T; Tura A; Kästenbauer T; Auinger M; Bieglmayer C; Wagner O; Kronenberg F; Nowotny P; Pacini G; Prager R Diabetes Care; 2006 May; 29(5):1031-8. PubMed ID: 16644633 [TBL] [Abstract][Full Text] [Related]
24. The effect of different glucose endovenous administrations on amylin and insulin blood concentration in healthy subjects. Testa I; Ceneralli S; Testa R; Bonfigli AR; Recchioni A; Paoletti P; De Sio G Boll Soc Ital Biol Sper; 1996; 72(3-4):103-8. PubMed ID: 8771910 [TBL] [Abstract][Full Text] [Related]
25. Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects. van Jaarsveld BC; Hackeng WH; Lips CJ; Erkelens DW Diabet Med; 1993 May; 10(4):327-30. PubMed ID: 8508614 [TBL] [Abstract][Full Text] [Related]
26. Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents. Gulli G; Rossetti L; DeFronzo RA Metabolism; 1997 Oct; 46(10):1157-61. PubMed ID: 9322799 [TBL] [Abstract][Full Text] [Related]
27. Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin. Jamal H; Bretherton-Watt D; Suda K; Ghatei MA; Bloom SR J Endocrinol; 1990 Sep; 126(3):425-9. PubMed ID: 2212934 [TBL] [Abstract][Full Text] [Related]
28. Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid. Andrikopoulos S; Verchere CB; Teague JC; Howell WM; Fujimoto WY; Wight TN; Kahn SE Diabetes; 1999 Oct; 48(10):1962-70. PubMed ID: 10512360 [TBL] [Abstract][Full Text] [Related]
29. The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in cats. Johnson KH; O'Brien TD; Jordan K; Betsholtz C; Westermark P Biochem Biophys Res Commun; 1990 Mar; 167(2):507-13. PubMed ID: 2182015 [TBL] [Abstract][Full Text] [Related]
30. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Gebre-Medhin S; Mulder H; Pekny M; Westermark G; Törnell J; Westermark P; Sundler F; Ahrén B; Betsholtz C Biochem Biophys Res Commun; 1998 Sep; 250(2):271-7. PubMed ID: 9753619 [TBL] [Abstract][Full Text] [Related]
31. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Sanke T; Hanabusa T; Nakano Y; Oki C; Okai K; Nishimura S; Kondo M; Nanjo K Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848 [TBL] [Abstract][Full Text] [Related]
32. Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Eriksson J; Nakazato M; Miyazato M; Shiomi K; Matsukura S; Groop L Diabetologia; 1992 Mar; 35(3):291-3. PubMed ID: 1563587 [TBL] [Abstract][Full Text] [Related]
33. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Ludvik B; Clodi M; Kautzky-Willer A; Capek M; Hartter E; Pacini G; Prager R Diabetologia; 1993 Jan; 36(1):84-7. PubMed ID: 8436259 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule. Stridsberg M; Berne C; Sandler S; Wilander E; Oberg K Diabetologia; 1993 Sep; 36(9):843-9. PubMed ID: 8405756 [TBL] [Abstract][Full Text] [Related]
35. Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice. Ahrén B; Oosterwijk C; Lips CJ; Höppener JW Diabetologia; 1998 Nov; 41(11):1374-80. PubMed ID: 9833947 [TBL] [Abstract][Full Text] [Related]
36. Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: studies using a novel aortic catheterization technique. Arnelo U; Permert J; Larsson J; Reidelberger RD; Arnelo C; Adrian TE Endocrinology; 1997 Oct; 138(10):4081-5. PubMed ID: 9322915 [TBL] [Abstract][Full Text] [Related]
38. Islet amyloid polypeptide in Psammomys obesus: lack of correlation between insulin resistance and plasma IAPP levels. Duhault J; Boulanger M; Espinal J; Marquié G; Petkov P; Donev S; Jablenska R; Popov A Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):535-40. PubMed ID: 8061570 [TBL] [Abstract][Full Text] [Related]
39. Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes. Mulder H; Gebre-Medhin S; Betsholtz C; Sundler F; Ahrén B Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E684-91. PubMed ID: 10751203 [TBL] [Abstract][Full Text] [Related]
40. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Leckström A; Lundquist I; Ma Z; Westermark P Pancreas; 1999 Apr; 18(3):266-73. PubMed ID: 10206485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]